An advisory committee unanimously recommended approval of the drug for two of the most severe types of childhood epilepsy.
By Laurie McGinley, Washington Post
Sat, 06/23/2018 - 4:33am
An advisory committee unanimously recommended approval of the drug for two of the most severe types of childhood epilepsy.